Smart ring start-up Oura delays IPO amid market uncertainty

Oura postponed its $2.1B IPO citing market uncertainty, despite strong demand. Accelevation (ACCV) priced below range, raising $540M. Roze AI (RZAI) completed direct listing, up 149%. Six SPACs and three IPOs filed. Renaissance IPO Index up 16.4% YTD.

Oura, a smart ring maker, delayed its Nasdaq IPO citing market uncertainty. The company aimed to sell 50M shares, raising up to $2.2B at a $15B valuation. Oura reported strong earnings, with $907.8M revenue and $23.5M pretax profit in fiscal 2025. The delay follows a lawsuit alleging false advertising, but the company denies this influenced the decision.

Oura postponed its $2.2bn IPO, citing market uncertainty despite strong demand. It planned to sell 50M shares at $40-$44 each. The company is profitable, with 5.7M paid members and expects 90% revenue growth in 2026. Four companies postponed IPOs in the same week, according to Renaissance Capital.

Oura, maker of the Oura smart ring, delayed its $2.2B IPO despite strong demand, valuing it at up to $15B. The company planned to offer 50M shares at $40-$44 each but chose to wait due to market conditions. It would have listed on Nasdaq under the ticker OURA.

Oura, a smart ring maker, delayed its Nasdaq IPO due to market uncertainty, despite strong growth and profitability. The company reported $1.21 billion in revenue for the nine months ending in June, up 74% year-over-year, and plans 90% growth for its 2026 fiscal year. Oura had aimed to raise $2.2 billion at a $15 billion valuation, with 50 million shares priced between $40 and $44 each.

Oura postponed its Nasdaq IPO, citing market uncertainty, despite strong demand and revenue growth. The company planned to offer 50M shares at $40-$44, potentially raising $2.2B. Oura reported $1.21B revenue for the first nine months of 2026, up 74% YoY, with net income rising from $1.6M to $60.8M. The company aims to become a preventative-health platform, but faces competition and legal challenges.